GlaxoSmithKline and Theravance have been marching right along. All four of their next-generation long-lasting treatments were approved by the FDA, offering hope that a successful product launch ...

Read our privacy notice. GlaxoSmithKline's global head of yax, Melissa Geiger, shares the secrets to her success, including staying one step ahead of a fast-moving industry and switching off with ...

GlaxoSmithKline PLC is a pharmaceutical giant ... the GSK and Novartis Consumer businesses’ joint venture with great success. The EMpower 50 Advocates Role Models 2022 named Diana Conrad as ...

How did GlaxoSmithKline flourish in the financial ... What has changed to allow GSK to remain in this position of success? In times before the internet, corporations had secrets.

GlaxoSmithKline's Nucala met its primary endpoint ... we've positioned ourselves for success. And we share that positioning and all the analysis behind it with our members. Analyst’s Disclosure ...

But GlaxoSmithKline's CEO is executing on a concrete, goal-driven plan to rejuvenate the business. The plan is proceeding nicely. Key to the company's future success are the results of ongoing ...

GlaxoSmithKline (NYSE ... and decades of highly successful competition within their markets. For bargain-hunting investors, there's a lot to consider when it comes to which stock will make ...

Shares of GlaxoSmithKline Pharmaceuticals hit the 20 percent upper circuit at ₹2,421.30 per share on the BSE on Monday, ...

The article There Appears to Be No Easy Path to Success for GlaxoSmithKline and Theravance originally appeared on Fool.com. Get a brief on the top business stories of the week, plus CEO interviews ...